A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity

By afschroeder • May 21, 2026

Esquenazi A, Wein TH, Verduzco-Gutierrez M, Ayyoub Z, Page S, Harding S, Maisonobe P, Beneteau M, Patel A; DIRECTION study group. A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity. Adv Ther. 2026 May 20. doi: 10.1007/s12325-026-03635-y. Epub ahead of print. PMID: 42159955.

Tags: AbobotulinumtoxinA, Crossover study, General Internal Medicine, Head-to-head double-blind study, OnabotulinumtoxinA, Physical Medicine & Rehabilitation, Publications, safety, Upper limb spasticity

Dynamic Bayesian networks to predict loss of kidney function: a cross-institution use case in a large cohort with or at-risk of CKD

Petousis P, Gordon D, Duru OK, Norris KC, Tuttle KR, Nicholas SB, Bui AAT. Dynamic Bayesian networks to predict loss of kidney function: a cross-institution[...]

The association between 10-year cardiovascular risk and fracture incidence in postmenopausal women: a prospective analysis from the Women’s Health Initiative

Hossain R, Laddu D, Crandall CJ, Ensrud KE, Cauley JA, Gabriel KP, Haring B, Hardy ST, LeBoff MS, Manson JE, Schwartz AV, Shadyab AH, Watts[...]

Cervical Chondrosarcoma Presenting as a Painless Neck Mass: A Case Report

Richardson KJ, Johnson R, Chen L, Gurveen S. Cervical Chondrosarcoma Presenting as a Painless Neck Mass: A Case Report. Cureus. 2026 Apr 19;18(4):e107330. doi: 10.7759/cureus.107330.[...]